Home Page
Registration
Program
Presentation Schedule
Presenting Companies
Presenter News
Presenter Application
Executive Workshop
Advisory Board
Hotel & Travel
Media Information
About This Event
bio.org
BIO VentureForum West 2003
2002 Conference
Other BIO Events
|
 printer version
Presentation Schedule
Sort by: Date/Time or Presentation Category
|
| Wed. |
10:00 AM | 204C |
Acceptys, Inc. |
Antibodies |
| Tue. |
10:10 AM | 204C |
Aciont Inc. |
Drug Delivery |
| Wed. |
10:40 AM | 204C |
Acuity Pharmaceuticals |
Enabling Technologies |
| Tue. |
11:30 AM | 204A |
Aderis Pharmaceuticals, Inc. |
CNS/Neurology |
| Tue. |
10:30 AM | 204C |
Altea Therapeutics |
Drug Delivery |
| Tue. |
3:20 PM | 204C |
Alteris Therapeutics, Inc. |
Cancer |
| Tue. |
11:20 AM | 204C |
ALung Technologies, Inc. |
Cardiovascular |
| Wed. |
11:00 AM | 204C |
APT Therapeutics, Inc. |
Drug Discovery |
| Tue. |
2:20 PM | 204C |
Aptamera, Inc. |
Cancer |
| Tue. |
11:40 AM | 204A |
Artesian Therapeutics, Inc. |
Cardiovascular |
| Wed. |
10:00 AM | 204A |
Aureon Biosciences Corporation |
Cancer |
| Tue. |
10:00 AM | 204A |
Barrier Therapeutics, Inc. |
Dermatology |
| Wed. |
10:10 AM | 204C |
Bionaut Pharmaceuticals, Inc. |
Enabling Technology |
| Tue. |
9:40 AM | 204C |
BioRexis Pharmaceutical Corporation |
Antibodies |
| Wed. |
11:00 AM | 204A |
Biosyn, Inc. |
Infectious Diseases |
| Tue. |
10:20 AM | 204A |
BioVex Limited |
Cancer |
| Tue. |
3:30 PM | 204C |
Bonecraft LLC |
Musculoskeletal |
| Tue. |
4:00 PM | 204A |
Cardiokine Inc. |
Cardiovascular |
| Tue. |
2:40 PM | 204C |
Celator Technologies Inc. |
Cancer |
| Wed. |
9:50 AM | 204A |
CEPTYR, Inc. |
Metabolic |
| Wed. |
11:10 AM | 204C |
Chaperone Technologies, Inc. |
Infectious Diseases |
| Tue. |
2:50 PM | 204A |
CombinatoRx |
Drug Discovery |
| Wed. |
11:20 AM | 204C |
Cytochroma Inc. |
Drug Discovery |
| Tue. |
3:40 PM | 204C |
Cytokine PharmaSciences Inc. |
Autoimmune/Inflammation |
| Tue. |
9:50 AM | 204C |
DarPharma, Inc. |
CNS/Neurology |
| Tue. |
11:30 AM | 204C |
Eagle Vision Pharmaceutical Corp. |
Cardiovascular |
| Wed. |
10:10 AM | 204A |
EluSys Therapeutics, Inc. |
Cancer |
| Tue. |
10:00 AM | 204C |
EraGen Biosciences, Inc. |
Diagnostics |
| Tue. |
10:50 AM | 204A |
EXIMIAS Pharmaceutical Corp. |
Cancer |
| Tue. |
10:50 AM | 204C |
FemmePharma, Inc. |
Drug Delivery |
| Tue. |
11:40 AM | 204C |
Fluorous Technologies Incorporated |
Chemistry |
| Tue. |
10:40 AM | 204C |
Gel Med Sciences, Inc |
Drug Delivery |
| Tue. |
11:00 AM | 204C |
Gelifex, Inc. |
Biomaterial/Skin/Wound |
| Tue. |
10:30 AM | 204A |
Gemin X Biotechnologies Inc. |
Cancer |
| Wed. |
10:40 AM | 204A |
GliaMed, Inc. |
CNS/Neurology |
| Wed. |
9:50 AM | 204C |
GlycoMimetics, Inc. |
Inflammation |
| Wed. |
10:50 AM | 204C |
Glyconix Corp. |
Enabling Technology |
| Tue. |
3:30 PM | 204A |
Gryphon Therapeutics, Inc. |
Drug Discovery |
| Tue. |
3:50 PM | 204A |
Hydra Biosciences, Inc. |
Cardiovascular |
| Tue. |
3:50 PM | 204C |
ImmunoSite, Inc. |
Autoimmune/Inflammation |
| Tue. |
10:10 AM | 204A |
Intronn Inc. |
Gene/Cell Therapy |
| Tue. |
11:00 AM | 204A |
KeyCell Therapeutics |
Cancer |
| Tue. |
9:50 AM | 204A |
Linguagen Corp. |
Drug Discovery |
| Tue. |
3:10 PM | 204A |
Locus Pharmaceuticals, Inc. |
Drug Discovery |
| Wed. |
11:10 AM | 204A |
MacroGenics, Inc. |
Antibodies |
| Wed. |
10:30 AM | 204C |
MaxCyte, Inc. |
Gene/Cell Therapy |
| Tue. |
2:30 PM | 204A |
Merrimack Pharmaceuticals, Inc. |
Autoimmune/Inflammation |
| Wed. |
10:20 AM | 204A |
Neuronyx, Inc. |
Gene/Cell Therapy |
| Tue. |
3:20 PM | 204A |
Norak Biosciences, Inc. |
Drug Discovery |
| Wed. |
10:30 AM | 204A |
Nucleonics, Inc. |
Infectious Disease |
| Tue. |
3:00 PM | 204C |
Onconova Therapeutics Inc. |
Cancer |
| Tue. |
2:50 PM | 204C |
PBL Therapeutics |
Cancer |
| Wed. |
10:50 AM | 204A |
PhageTech Inc. |
Infectious Disease |
| Tue. |
2:40 PM | 204A |
Phenomix Corporation |
Autoimmune/Inflammation |
| Tue. |
4:00 PM | 204C |
PhysioAdvantage LLC |
Pulmonary |
| Tue. |
11:10 AM | 204A |
Prestwick Pharmaceuticals, Inc. |
CNS / Neurology |
| Wed. |
11:30 AM | 204A |
Protein Forest, Inc. |
Proteomics |
| Wed. |
11:30 AM | 204C |
Protez Pharmaceuticals Inc. |
Infectious Diseases |
| Tue. |
3:10 PM | 204C |
Rejuvenon Corp. |
Cancer |
| Wed. |
11:20 AM | 204A |
RenalTech International, LLC |
Renal |
| Tue. |
11:20 AM | 204A |
RetinaPharma Technologies, Inc. |
CNS/Neurology |
| Wed. |
10:20 AM | 204C |
Revivicor, Inc. |
Transplant |
| Tue. |
10:40 AM | 204A |
Salmedix, Inc. |
Cancer |
| Tue. |
3:40 PM | 204A |
Scion Pharmaceuticals Inc. |
Drug Discovery |
| Tue. |
3:00 PM | 204A |
Structural GenomiX, Inc. |
Drug Discovery |
| Tue. |
2:30 PM | 204C |
Targeted Diagnostics & Therapeutics, Inc. |
Cancer |
| Tue. |
10:20 AM | 204C |
Transave, Inc. |
Drug Delivery |
| Tue. |
9:40 AM | 204A |
TransTech Pharma, Inc. |
Drug Discovery |
| Tue. |
2:20 PM | 204A |
Triad Therapeutics, Inc. |
Autoimmune/Inflammation |
| Tue. |
11:10 AM | 204C |
X-Ceptor Therapeutics, Inc. |
Cardiovascular |
|
